Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
Corcept Therapeutics
Boston Scientific Corporation
Cedars-Sinai Medical Center
AstraZeneca
AstraZeneca
Revolution Medicines, Inc.
NiKang Therapeutics, Inc.
Genelux Corporation
The Netherlands Cancer Institute
Cogent Biosciences, Inc.
Thomas Jefferson University
University of Arkansas
The First Affiliated Hospital with Nanjing Medical University
Promontory Therapeutics Inc.
Nanfang Hospital, Southern Medical University
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Weill Medical College of Cornell University
The Second Affiliated Hospital of Fujian Medical University
Hoffmann-La Roche
Jiangxi Provincial Cancer Hospital
Zhejiang University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Gachon University Gil Medical Center
Jiangsu Cancer Institute & Hospital
Jiangsu Cancer Institute & Hospital
University College, London
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Daiichi Sankyo
Sinocelltech Ltd.
Royal Marsden NHS Foundation Trust
Yale University
Dendreon
Instituto Nacional de Cancer, Brazil
Novartis
Merck KGaA, Darmstadt, Germany
Rigshospitalet, Denmark
Steba Biotech S.A.
Assistance Publique - Hôpitaux de Paris
Steba Biotech S.A.
SciClone Pharmaceuticals
Assistance Publique - Hôpitaux de Paris
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Shandong Cancer Hospital and Institute
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Faculdade de Medicina do ABC
Eli Lilly and Company